Mealey's (April 17, 2023, 12:03 PM EDT) -- WASHINGTON, D.C. — A circuit judge sitting by designation in the District of Delaware did not err in declaring various claims of a patent directed to transdermal rotigotine patches for the treatment of Parkinson’s disease invalid as obvious, the Federal Circuit U.S. Court of Appeals concluded....